News & Updates

A 6-month-long lifestyle walking intervention improves daily steps by about 25 percent in patients with heart failure (HF), although this improvement fails to translate to better functional capacity, according to the results of the WATCHFUL* trial.

Among hospitalized patients treated with direct oral anticoagulants (DOACs), an elevated international normalized ratio (INR) upon admission may spell an increased risk for in-hospital death or mortality during the first year following hospitalization, suggests a study.

Older patients who are taking oral anticoagulants (OAC) for atrial fibrillation (AF) benefit from a reduced risk of stroke and all-cause mortality, reports a study. Moreover, nonvitamin K oral anticoagulants (NOAC) exhibit superiority over vitamin K agonists (VKA), with less mortality and major bleeding among its users.

The use of hydroxychloroquine during pregnancy does not appear to reduce the risk of pre-eclampsia among women with systemic lupus erythematosus, as shown in a study.

A scientific statement endorsed by the American Heart Association (AHA) has urged cardiothoracic surgeons to get more involved in the care of patients at high risk for pulmonary embolism (PE) – and to do it much earlier – to improve outcomes.

Expectant mothers with high blood pressure (BP) levels before pregnancy are at increased risk of adverse pregnancy outcomes, as reported in a study.

In patients who have had a first attack of pericarditis with evidence of myocardial involvement, treatment with colchicine is safe and helps reduce the risk of recurrence, according to a study.

Being fat contributes to the development of cardiopulmonary (CP) multimorbidity (MM), reports a study. As a result, adiposity may be targeted by future interventions to help prevent MM.